PULMATRIX, INC. Selling, General and Administrative Expense
PULMATRIX, INC. (PULM) reported Selling, General and Administrative Expense of $4.53 million for the 12-month period ending 2015-03-31, per its 10-K filed 2015-06-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2015-06-10
- PULMATRIX, INC. selling, general and administrative expense for the quarter ending 2015-03-31 was $1.30M, a 94.05% increase year-over-year.
- PULMATRIX, INC. selling, general and administrative expense for the quarter ending 2014-12-31 was $1.10M, a 317.11% increase year-over-year.
- PULMATRIX, INC. selling, general and administrative expense for the quarter ending 2014-09-30 was $1.09M, a 117.64% increase year-over-year.
- PULMATRIX, INC. selling, general and administrative expense for the quarter ending 2014-06-30 was $1.04M, a 245.36% increase year-over-year.
- PULMATRIX, INC. selling, general and administrative expense for fiscal 2015 was $4.53M, a 160.94% increase from fiscal 2014.
- PULMATRIX, INC. selling, general and administrative expense for fiscal 2014 was $1.74M.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2015-03-31 | $1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2015-06-10 | $2.40M derived: sum of 2 quarters · filed 2015-06-10 | $3.49M derived: sum of 3 quarters · filed 2015-06-10 | $4.53M 10-K · filed 2015-06-10 |
| 2014-12-31 | $1.10M 10-Q · filed 2015-02-13 | $2.18M derived: sum of 2 quarters · filed 2015-02-13 | $3.23M 10-Q · filed 2015-02-13 | $3.90M derived: sum of 4 quarters · filed 2015-06-10 |
| 2014-09-30 | $1.09M 10-Q · filed 2014-11-13 | $2.13M 10-Q · filed 2014-11-13 | $2.80M derived: sum of 3 quarters · filed 2015-06-10 | $3.06M derived: sum of 4 quarters · filed 2015-06-10 |
| 2014-06-30 | $1.04M 10-Q · filed 2014-08-14 | $1.72M derived: sum of 2 quarters · filed 2015-06-10 | $1.98M derived: sum of 3 quarters · filed 2015-06-10 | $2.48M derived: sum of 4 quarters · filed 2015-06-10 |
| 2014-03-31 | $672.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-06-10 | $935.00K derived: sum of 2 quarters · filed 2015-06-10 | $1.43M derived: sum of 3 quarters · filed 2015-06-10 | $1.74M 10-K · filed 2015-06-10 |
| 2013-12-31 | $263.00K 10-Q · filed 2015-02-13 | $762.00K derived: sum of 2 quarters · filed 2015-02-13 | $1.06M 10-Q · filed 2015-02-13 | |
| 2013-09-30 | $499.00K 10-Q · filed 2014-11-13 | $801.00K 10-Q · filed 2014-11-13 | ||
| 2013-06-30 | $302.00K 10-Q · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |